Previously, we demonstrated that exogenous heat shock protein 27 (HSP27/gene, HSPB1) treatment of human endothelial progenitor cells (EPCs) increases the synthesis and secretion of VEGF, improves EPC-migration/re-endothelialization and decreases neo-intima formation, suggesting a role for HSPB1 in regulating EPC function. We hypothesized that HSPB1 also affects mature endothelial cells (ECs) to alter EC-mediated vasoreactivity in vivo. Our work focused on endothelial NOS (eNOS)/NOdependent relaxation induced by ACh and the coagulation pathway-activated receptor, proteinase-activated receptor 2 (PAR2).
Introduction
Heat shock protein 27 (HSP27: human) and its murine orthologue, HSP25, are members of the small HSP family that is recognized for its ATP-independent chaperone activity as well as for other intracellular effects (e.g. preventing apoptosis) (Acunzo et al., 2012; Garrido et al., 2012; Addis et al., 2014; Bakthisaran et al., 2015) . Along with two other groups, our laboratory noted that the expression of HSP27 diminishes with the development of atherosclerosis (Martin-Ventura et al., 2004; Miller et al., 2005; Park et al., 2006) . Recently, HSP27 was shown to play an important extracellular role, wherein it can signal to activate NF-κB via scavenger and innate immune response receptors, in particular, toll-like receptor 4 (TLR4; Salari et al., 2013; Alexander et al., 2015; Batulan et al., 2016; Arrigo, 2017; Pulakazhi Venu et al., 2017) . Moreover, studies from our group demonstrated that augmenting HSP27 levels by overexpressing the protein, administering the recombinant protein (rHSP27) or transplantation of bone marrow from HSP27-overexpressing mice protects against atherogenesis, lowering both plaque and serum cholesterol levels (Rayner et al., 2008; Seibert et al., 2013) . Interestingly, oestrogens facilitate the expression and extracellular release of HSP27 -an effect that is abolished with the loss of ovarian function (Porter et al., 1996; Rayner et al., 2009) . HSP27 also has an impact on endothelial progenitor cell proliferation and migration in vitro that appears to stem from its ability to trigger VEGF production (Miller et al., 2005; Ma et al., 2014) . Thus, HSP27 plays an important role in regulating the optimal differentiation of the endothelium; but its impact on the vasoregulation of the endothelium in a mature intact vessel has not yet been determined. Vascular tension is regulated by a variety of endotheliumderived vasorelaxants, including NO (Furchgott and Zawadzki, 1980) , prostacyclin (Moncada et al., 1976) and endothelium-derived hyperpolarizing factors (now termed, EDH; Vanhoutte, 2009, 2013) , such as H 2 O 2 and epoxyeicosatrienoic acid (EET) (Shimokawa et al., 1996; Edwards et al., 1998; Feletou and Vanhoutte, 2009; Vanhoutte et al., 2009; Edwards et al., 2010; Shimokawa, 2010; Ohashi et al., 2012; Triggle et al., 2012; Wong et al., 2014) . In many studies, a vasodilatation/relaxant response to activation of the muscarinic ACh receptor (Challiss and Tobin, 2018 ) is used to probe the mechanisms whereby endothelium-derived factors affect vessel tension. That said, we suggest that vasorelaxation due to the activation of endothelial proteinase-activated receptors (PARs), which are regulated by coagulation proteinases, represents a more physiological response relevant to the functioning of vessels in vivo (Ramachandran, 2012) . Of note for our work, HSPB1, the human gene for HSP27, is one of the genes transcribed in response to PAR activation (Saban et al., 2007) . We therefore hypothesized that there would be a link between the systemic abundance of HSPB1 and PAR-mediated NOdependent vasorelaxation that would parallel the impact of HSPB1 on muscarinic receptor-stimulated vasorelaxation caused by ACh.
To explore this possible relationship between HSPB1 and agonist-mediated endothelial function, we evaluated PAR2-regulated endothelial vasorelaxation/vasodilatation (Bunnett et al., 2018) in isolated aortic rings derived from male and female wild-type mice along with those that were either HSPB1-null or which overexpressed HSPB1 (Hspb1 o/e ).
The vascular responses of these mice were compared for both male and female mice. The PAR2-mediated relaxant responses in the aortic ring preparations were compared with the responses induced by ACh. Vasodilatation was measured both in the absence and presence of concentrations of the NOS inhibitor L-NAME (0.1-0.3 mM) that in routine experiments blocks endothelium-mediated NO-dependent vasorelaxation in rodent vascular preparations. This inhibitor was used both alone and in combination with ODQ (1 μM) that blocks residual NO-stimulated soluble guanylyl cyclase activity. Mice of either sex were studied because previous work has shown differences in the ultrastructure of endothelial cells obtained from male compared to female mice (Addis et al., 2014) , and because HSPB1 is differently expressed in males and females due to the impact of oestrogen on HSPB1 transcription. We, therefore, also evaluated the effect of exogenously added HSPB1 in tissues isolated from ovarectomized mice and in terms of a potential impact on systemic blood pressure.
Methods

Tissue isolation and wire-myography
All experiments were done with male (n = 12 mice) and female (n = 12 mice) age-matched 8-12 week old (20 to 25 g) wild-type, Hspb1-null (HSPB1 À/À ) mice provided by Dr. Jonathan L.E. Dean (C57BL6 background, Oxford University, UK) (Crowe et al., 2013) and with HSPB1-overexpressing mice (HSPB1 o/e ) provided by Imperial College London, UK (C57BL10/CBACA background; Sharp et al., 2006) . Tissues were also obtained from female wild-type, HSPB1-null and HSPB1-overexpressing mice which were either intact or ovariectomized one month prior to tissue harvest. The procedure for ovariectomy was as previously described (Idris, 2012; Ström et al., 2012) . Mice were maintained in individual colonies in the University of Calgary Faculty of Medicine vivarium Experiments were done in accordance with protocols approved by the Faculty of Medicine Animal Care Committee. Mice were housed in Tecniplast ventilated cage systems under specific pathogen-free conditions (standard 12 h light/dark cycle), with wood shaving-based bedding, free access to chow and autoclaved water, and housed with no more than five animals per cage. All mice were randomly allocated to cages designated for specific genotype and gender by vivarium staff, upon transfer from the breeding barrier unit into the animal housing room. Animal studies are reported in compliance with the AR-RIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Animals were treated with heparin (1000 IU.mL -1 i.p.) before they were killed 10 min later by cervical dislocation. Isometric tension studies using a Mulvany-Halpern myograph as outlined above were performed essentially as described previously (Norata et al., 2012; Saifeddine et al., 2015) . In brief, descending aortic tissue was cut into 2-3 mm long and 1 mm diameter rings and mounted in the wire-myograph (610 multimyograph system couple to Chart 5 system software, AD instruments, Colorado Springs, CO, USA). Tissues were obtained from eight or more mice per gender per genotype for our study. All assays were performed in Krebs buffer, and resting tension (1 g = 4.8 mN) was maintained for 1 h prior to all experiments. All experiments were performed at 37°C in the above-described Krebs bioassay buffer. After a 60 min equilibration period, tissue viability was verified by monitoring a contraction in response to the addition of 80 mM KCl to the organ bath. The integrity of the endothelium was verified by contracting the tissue with phenylephrine (PE: 2.5 μM) and then monitoring a relaxation caused by ACh (3 μM). Tissues were washed 3 times after reaching an equilibrium tension and allowed to re-equilibrate in bioassay buffer for 20 min prior to the next addition of agonists to the organ bath. After the responsiveness of the tissues to constriction and endothelium-dependent relaxation had been validated, the following experimental protocols were pursued.
Contractile responses and impact of endogenous NO release. The tissue responses above baseline tension (g tension) were measured for increasing concentrations of PE. To assess the impact of spontaneous endothelial NOS (eNOS)-dependent endogenous NO release on the PE-induced contractile response, measurements were made in the absence and presence of the eNOS inhibitor, L-NAME (0.1 mM), or the guanylyl cyclase inhibitor, ODQ (1 μM), either alone or in combination with L-NAME to quench residual NO-mediated guanylyl cyclase activity.
Vasodilator responses. Measurements of reduced tension (vasodilatation) in PE-constricted vessels were used to document the equivalent of vasodilatation caused by the agonists in our work. Concentration-effect curves for endothelium-dependent vasodilatation induced by ACh and the PAR2-selective agonist, 2-furoyl-LIGRLO-NH 2 (2-fLI), were measured upon contracting the tissues with PE (2.5 μM), followed by the addition of increasing concentrations of ACh or 2-fLI to the organ bath. Relaxant responses were also evaluated in the presence of inhibitors where tissues were pretreated for 20 min prior to contracting the tissues with PE and then adding an endothelium-dependent vasodilator/relaxant agonist (ACh or 2-fLI) to the organ bath.
Agonist-mediated relaxation was quantified as % relaxation relative to the tension generated by PE in the same tissue: % relaxation = [(PE tension À tension after endotheliumdependent relaxation)/original PE tension]} × 100).
In the presence of inhibitors, the % inhibition was calculated according to the following formula: % inhibition-= [(% relaxation minus inhibitor À % relaxation with inhibitor)/% relaxation minus inhibitor] × 100.
Use of inhibitors of eNOS, ODQ, K Ca conductance channels and other targets
As outlined above, the inhibitors of eNOS (L-NAME: 0.1 mM) and guanylyl cyclase (ODQ, 1 μM) (both from Sigma-Aldrich Canada, Oakville, ON, Canada) were employed either alone or in combination. Also, a selection of inhibitors of small (SK ca ), intermediate (IK ca ) and large (BK ca ) conductance channels was used. Those K Ca channel inhibitors included apamin (1 μM, SK Ca : Sigma-Aldrich Canada), TRAM 34 (1 μM, IK Ca : Sigma-Aldrich Canada), charybdotoxin (100 nM, IK Ca /BK Ca : from Sigma-Aldrich Canada) and iberiotoxin (100 nM, BK Ca : from Cayman Chemicals, Burlington, ON, Canada), used either alone or in combination. A potential relaxant role for EET was assessed by the use of the EET antagonist, 14,15-epoxyeicosa-5(Z)-enoic acid (14,15 EEZE) (from Tocris, Minneapolis, MN, USA). Finally, the effect of indomethacin (10 μM: Sigma-Aldrich Canada) to block relaxant prostanoid production was evaluated. The inhibitor concentrations used were in keeping with those selective for the targeted enzymes, as employed routinely in the published literature. Inhibitors were added either alone or in combination directly to the organ bath 10 min prior to the addition of vascular agonists to the tissues. All inhibitors were dissolved in distilled water except TRAM-34 which was dissolved in reagent-grade DMSO. Indomethacin (final concentration in the organ bath, 1 to10 μM) was dissolved in absolute ethanol.
Blood pressure measurements in mice
Anaesthesia was induced in mice using 4% isoflurane with oxygen as a carrier gas. The mice were then placed on a heated surgical table and anaesthesia was maintained with 2% isoflurane. The right carotid artery was isolated taking care not to disturb the right vagus nerve. Subsequently, a 1 Fr. pressure transducer (Millar Instruments) was advanced down the right carotid artery into the ascending portion of the aorta in order to measure aortic blood pressure. Care was taken to avoid obstructing the aortic valve. Blood pressure measurements were recorded and analysed using Lab Chart (ADI Instruments). After the pressure transducer was located properly in the ascending aorta, the left jugular vein was isolated and cannulated using Polyethylene 10 tubing for the subsequent administration of various doses of agonists in the following order: PE (0.2 mg·kg À1 ), ACh (0.2 mg·kg À1 ) and 2-fLI (0.78 mg·kg À1 ), administered intrajugularly as a 1 μM solution in isotonic saline in a volume of 30 μL over 5 s. After the administration of each drug, the cannula was flushed with saline to clear the line and at least 5 min was allowed to pass prior to the administration of the next dosage. At the end of each experiment, the mice were killed by cervical dislocation.
Recombinant HSP27 and inactive truncated HSP27 protein (rC1)
Recombinant HSP27 (rHSP27) and an inactive HSP27 N-terminal truncated mutant of HSP27 (rC1) were generated and purified as previously described using Ni-NTA resin affinity chromatography (Qiagen, Valencia, CA, USA) and refolded by dialysis. After removal of endotoxin with Detoxi-gel columns (Fisher Scientific, Pittsburgh, PA, USA), the purity of the final rHSP27 and rC1 protein was more than 95% by SDS-PAGE and the endotoxin concentration was <5 EU·mg À1 protein (LAL assay).
Evaluation of aorta tissue treated with recombinant HSP27. Aorta tissues harvested from female HSPB1-null mice were cultured for either 3 or 24 h at 37°C in serum-free DMEM containing 10 mM glucose (a euglycaemic value for mice), GlutaMAX ™ supplement, with pyruvate (Life technologies, Canada, CAT #10567014), either in the absence or presence of 50 μg·mL À1 (2.2 μM) recombinant rHSP27 prepared as previously described . At either 3 or 24 h, the tissue was dissected into rings for the bioassay as outlined above to assess the size of the L-NAME-resistant relaxation induced in the tissues by either ACh or the PAR2 agonist, 2-fLI.
qPCR method
The mRNA levels of eNOS and the α-subunit isoforms of murine guanylyl cyclase, Gucy1a2 and Gucy1a1 mRNAs in mouse aorta tissues were measured by real-time PCR. Aorta tissue was isolated by dissection from male and female mice (8 to 12 weeks of age), cleaned from perivascular adipose tissues, snap-frozen and ground using beads (Beads Lysis green kits for tough tissue, Next Advance, Inc., Troy, NY, USA) and supplemented with RNA Shield buffer (Zymo Research, Irvine, CA, USA). The tissues were homogenized for 10 min with a Bullet Blender (Next Advance, Inc.). RNA was extracted with a Zymo Mini plus kit according to the manufacturer's protocol (Zymo Research). cDNA was synthesized with SuperScript IV (ThermoFisher, Waltham, MA, USA), and real-time PCR amplification was done using StepOne Real-Time PCR system with PowerUp SYBR Green Master Mix (ThermoFisher).
Since the amounts of total RNA from aorta tissues are very small and cannot be readily quantified spectrophotometrically, we used all of the purified total RNA to synthesize cDNA and then standardized/normalized our qPCR data according to the abundance of mRNA for the TATA binding protein, TBP (gene accession number: NM_013684.3), which we determined to be a more reliable comparator than GAPDH. We tested several 'house-keeping' genes as internal controls, and we selected TBP because we found that the TBP primer set has 100% efficiency for the PCR cycle number and follows a stoichiometric concentration-response/qPCR relationship validated with RNA derived from mouse kidney tissue. We validated the primer sets for murine eNOS (gene accession number: NM_008713.4) and two murine guanylate cyclase isoforms (Gucy1a2: Gene accession number, NM_001033322.2 and Gucy1a1: Gene accession number, NM_021896.6). The primer pair sequences were as follows: for eNOS -Forward -GGTCCTGTGCATGGAT GAG; Reverse -GTTGTACGGGCCTGACATTT; Gucy1a2 -Forward -TGGGTGGTGTGGGGGAAAAG; Reverse -ACCTGC ATGGCTGACAAACAA; Gucy1a1 -Forward -TTCTCACACAC CGCCTTCT; Reverse -GCTGGTGTTGATGTGGACTGA; TBP -Forward -CATCTCAGCAACCCACACAG; Reverse -GGGG TCATAGGAGTCATTGG.
Concentration-response curves and statistics
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . The mean log concentration-response curves to agonists were analysed by fitting data to a four-parameter logistic equation (given below) using nonlinear regression [pEC 50 log(agonist) versus response -variable slope (four parameters)] (GraphPad Prism):
where X is the logarithm of the molar concentration of agonist, Y is the response and n H is the Hill slope. Top is equal to the maximum contraction (E max ), and log EC 50 is the agonist concentration that produces 50% of the maximum response. Bottom is equal to the resting tone in the absence of any contractile agonist (Hennessey and McGuire, 2013) . Data points in the figures represent the mean ± SEM (bars in figures) of five or more independent experiments done on tissue preparations from eight or more different animals. Error bars smaller than the symbols shown in the figures are not visible. Statistical comparisons between data points were made using either Student's unpaired t-test when comparing two groups or a one-way ANOVA, with Tukey's multiple comparison test when comparing multiple groups. In all cases, a significant difference was considered at P < 0.05.
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017a,b,c) .
Results
Phenylephrine-mediated increases in tension
We aimed to evaluate aorta tissue function in vitro. To this end, we studied both the increased tension in the tissues due to the action of PE on the smooth muscle elements and the NO-mediated relaxant/vasodilator responses stimulated by ACh and the receptor-selective PAR2 agonist, 2-fLI. Increasing concentrations of PE caused a graded increase in grams tension in tissues from all animals, indicating that the contractile responses were fully functional ( Figure 1 and Supporting Information Figure S1A for representative tracings). The maximum tension generated by PE alone was comparable between the different tissues, ranging from about 0.45 to 0.6 g with a maximum response observed in the range of 2.5 μM PE. That concentration of PE was thus used in further experiments to contract the tissues prior to testing the relaxant effects of 2-fLI and ACh activation.
When the inhibitor of eNOS (L-NAME, 0.1 mM) was added, the contractile action of PE was enhanced in all tissues; and a comparable enhancement of contractility was caused by the addition of the guanylyl cyclase inhibitor, ODQ (1 μM) (compare magenta circles vs. orange squares and green triangles in Figure 1 ). The contractile response was maximal in the combined presence of both L-NAME and ODQ. These data indicated either that there was a constitutive release of NO by the tissues or that the α-adrenergic contractile agonist, PE, concurrently triggered eNOS activation; and that the inhibition of eNOSgenerated NO production with L-NAME along with blocking guanylyl cyclase with ODQ enhanced the contractions. This enhanced action of PE was seen in all tissues from both males and females to a comparable degree. The maximal contractile responses of the tissues in the presence of L-NAME (between 1 and 1.5 g) did not differ significantly amongst the tissues.
Sodium nitroprusside-induced vasorelaxation
To determine if the aorta tissues derived from the different mouse strains were differentially sensitive to NO-mediated relaxation, we measured the concentration-relaxation curves for the NO-donor, sodium nitroprusside (SNP; Supporting Information Figure S2 ). When tissues were contracted with PE (2.5 μM), the EC 50 for SNP-mediated relaxation was not significantly different for tissues derived from the three strains of female mice (Supporting Information Figure S2A ). The EC 50 for the aorta tissue obtained from the HSPB1-overexpressing male mice (2 nM) was the same as for the female-derived tissues (2 nM). However, the aorta tissues from the male HSPB1-null mice were less sensitive to SNP than female-derived tissue, with an EC 50 of 8.1 nM (Supporting Information Figure S2 ; P < 0.05 for differences between the male HSPB-1 nullderived tissues vs. tissues from the wild-type or HSPB1-overexpressing mice). That said, all of the male-derived tissues were equally responsive to elevated concentrations of SNP in the range of 20 nM and higher. Thus, there was not a uniform rightward-shift in the SNP concentration-effect curve for the male-derived tissues.
To sum up, the contractile responses to PE were not changed in the mice either by the deletion or overexpression of HSP27; and we found that there were no significant differences in the sensitivity of the female tissues from the majority of tissues from the different mouse strains for SNPstimulated relaxation. Nonetheless, there was a difference in the EC 50 for the SNP response of the HSPB1-null male tissues compared with the wild-type and HSPB1-overexpressing mice. However, the maximum responsiveness to SNP did not differ between the male-derived tissues. Having established the equivalent contractile response of the tissues to PE and the comparable sensitivity of the female tissues to SNP-mediated relaxation, with only small differences in smooth muscle responsiveness towards NO in the HSPB1-null male-derived tissues, we went on to evaluate the endothelial function in aorta rings from the mice.
Lack of HSPB1 results in an increased L-NAME-resistant ACh-mediated vasodilator response in tissues from female but not male mice
The action of ACh was comparable in the three strains of female mice, causing a 70 to 80% vasodilatation/relaxation of the tissues at 1 to 10 μM ACh (Figure 2A-C) . That said, the impact of the NOS inhibitor, L-NAME (0.1 mM), on the vascular response differed significantly between the preparations from the different strains of mice. The concentration of L-NAME used (0.1 mM) was in keeping with its ability to block PAR2 and muscarinic receptor-mediated endothelium-mediated vasodilatation completely in rodent aorta tissues used by us previously (Al-Ani et al., 1995) . At this concentration, L-NAME was able to block 80% or more of the relaxation triggered by ACh in the rings from the male mice ( Figure 2D-F) and from the wild-type and HSPB1-overexpressing female mice (Figure 2A , C), in accord with our previous findings for the action of 0.1 mM L-NAME in male rodent-derived aorta tissue. However, in tissues from the HSPB1-null females, there was a significant amount of L-NAME-resistant vasodilatation/relaxation, accounting for 40% of the relaxant response caused by ACh in the absence of L-NAME ( Figure 2B) .
Given that the ACh-mediated vasorelaxant effect in the presence of 0.1 mM L-NAME could be due to the stimulation of guanylyl cyclase by residual NO, as shown by Cohen et al. (1997) for ACh action in rabbit carotid artery tissue, we therefore treated the tissues with an inhibitor of soluble guanylyl cyclase, ODQ, either alone or in combination with L-NAME.
Figure 1
Concentration-response curves for the contractile action of phenylephrine (PE) in the absence and presence of L-NAME or ODQ acting alone or in combination. Increased tension (g) in response to increasing concentrations of PE was measured in the absence or presence of L-NAME (0.1 mM) as outlined in the Methods for tissues from female (A-C) and male (D-F) wild-type (A, D), HSPB1-null (B, E) and HSPB1-overexpressing (C, F) mice. Lines represent four parameter logistic curves, which calculate the variables available on GraphPad PRISM. Variables were compared by one-way ANOVA followed by post hoc tests. *P < 0.05, PE alone versus + L-NAME alone; ODQ alone and in combination with L-NAME and ODQ.
As for L-NAME, ODQ alone was able to block 90% or more of the ACh-induced vasodilator response in the male-derived tissues and in the wild-type and HSPB1-overexpressing female mice (Figure 2A , C-F); but like L-NAME, ODQ acting on its own was able to block only 60% of the ACh-stimulated vasodilatation observed in tissues from the HSPB1null females ( Figure 2B ). However, in the combined presence of L-NAME and ODQ, the ACh-triggered vasorelaxant responses were eliminated in all tissues (Figure 2A-F) .
Lack of HSPB1 results in an increased L-NAME-resistant PAR2-triggered vasodilatation response, in keeping with the responses to muscarinic receptor activation
Next, we focused on PAR2-mediated vasodilatation/ relaxation in comparison with the actions of ACh. 2-fLI is a well-established receptor-selective PAR-2 agonist that can cause both NO-dependent and EDH-dependent relaxation in different vessels (McGuire et al., 2002; McGuire et al., 2004a,b) . In all tissues, activation of PAR2 with 2-fLI (up to 1 μM) caused a relaxation of 75% or more relative to the tension generated by PE in both female-and male-derived rings (Figure 3 and Supporting Information Figure S1B for representative tracings). In previous work with aorta rings derived from male rats and mice, we found that the aorta relaxant response to PAR2 activation was entirely endothelium-dependent and was predominantly due to the eNOS-triggered/L-NAME-inhibited release of NO (Al-Ani et al., 1995; Saifeddine et al., 1996) . In keeping with our previous results obtained with aorta tissues from male rodents in which PAR2 and muscarinic-stimulated vasodilatation/relaxation is endothelium-dependent, L-NAME (0.1 mM) was able to block over 80% of the vasodilator/relaxant response to PAR2 activation in the male mouse-derived aorta rings ( Figure 3D -F and Supporting Information Figure S1C , D showing representative tracings for males and females). However, in the wild-type female mice, the proportion of L-NAME-resistant relaxation in response to PAR2 activation was significantly larger (P < 0.05) than in the male-derived tissues. In tissue from the wild-type females treated with 0.1 mM L-NAME, there was still a 40% relaxation relative to the maximum relaxation caused by 2-fLI in the absence of L-NAME ( Figure 3A ). This L-NAME-resistant relaxation can be compared to a 5% relaxation in the L-NAME-treated male-derived tissues ( Figure 3D ). This PAR2 action can be compared to the much smaller degree of L-NAME-resistant relaxation (about 20%) caused by ACh (P < 0.05, for ACh compared to PAR2) in the wild-type female-derived tissue (Figure 2A) . Further, the proportion of L-NAME-resistant relaxation caused by PAR2 activation in tissues from the HSPB1-null female mice was even greater (up to 60% of the relaxation caused in the absence of L-NAME; Figure 3B ; P < 0.05 for HSPB-1-derived female tissues vs.
Figure 2
ACh-mediated relaxant responses observed in the absence or presence of L-NAME and ODQ acting alone or in combination. PE-constricted aorta tissues from female (A-C) and male (D-F); wild-type (wt/wt) (A, D), HSPB1-null (À/À) (B, E) and HSPB1-overexpressing (o/e) mice (C, F) were treated with increasing concentrations of ACh either in the absence or presence of 0.1 mM L-NAME or 1 μM ODQ acting either alone or in combination (L-NAME plus ODQ), and the relaxant responses were measured as outlined in the Methods. Lines represent four parameter logistic curves which calculate the variables available on GraphPad PRISM. Variables were compared by one-way ANOVA followed by post hoc tests. *P < 0.05 PE alone versus + L-NAME alone; #P < 0.05, + L-NAME alone and ODQ alone versus +L-NAME and ODQ.
wild-type) than the response observed for tissues from the wild-type female mice (40% resistant to L-NAME; Figure 3A ). In contrast, the proportion of L-NAME-resistant PAR2-mediated relaxation in the rings from the females overexpressing HSPB1 (about 10% vasodilatation; Figure 3C ) was equivalent to the small proportion observed for all of the male-derived tissues (compare Figure 4C with Figure 3-F) . In the assays using all of the male and female tissues, the relaxant effects of either ACh or 2-fLI were not affected in the presence of indomethacin (1 to 10 μM) either alone or in combination with 0.1 mM L-NAME (not shown). We concluded that aorta rings derived from the female mice, compared with male-derived tissues, exhibit a higher proportion of L-NAME-resistant PAR2-mediated relaxation and that the absence of HSPB1 in the females enhances this effect. Further, we concluded that the overexpression of HSPB1 in the females attenuates the L-NAME-resistant response in the tissues.
The data obtained for PAR2-mediated vasodilatation in the absence and presence of L-NAME and ODQ acting alone were comparable to those obtained for muscarinic activation, in that L-NAME and ODQ alone were able to attenuate the PAR2-stimulated vasorelaxant response in all of the malederived tissues ( Figure 3D-F) . Further, the vasorelaxant response was eliminated in all tissues (both male and female) in the combined presence of L-NAME and ODQ (Figure 3) . However, the impact of ODQ alone on the PAR2-induced vasorelaxant response in tissues from the wild-type and HSPB1-null female mice differed from its effect on AChinduced vasorelaxation (compare Figures 2 and 3) . Thus, ODQ acting on its own on the tissues from the female mice had a greater effect than L-NAME (P < 0.05) and was able to eliminate more than 80% of the vasodilator effect of 2-fLI activation in tissues both from the wild-type and from the HSPB1-null female mice. In contrast, as recorded above, L-NAME alone blocked only 40% (HSPB-1-null female tissue) to 60% (wild-type female tissue) of the PAR2-stimulated vasodilator response ( Figure 3A, B) .
Elevated extracellular potassium and inhibitors of calcium-activated K Ca channels attenuate relaxation in the presence of L-NAME
Because previous work with rabbit carotid artery issue showed that hyperpolarization-mediated vasodilatation could result from residual NO, even in the presence of up to 0.3 mM L-NAME (Cohen et al., 1997) , we assessed the impact of elevated K + concentrations on the relaxant response to ACh and 2-fLI in the presence of L-NAME. Indeed, the vasodilator effects of both ACh and 2-fLI, when acting in the presence of 0.1 mM L-NAME, were diminished by supplementing the organ bath with 15 mM KCl, indicating that hyperpolarization
Figure 3
2-fLI/PAR2-mediated relaxant responses observed in the absence or presence of L-NAME and ODQ acting either alone or in combination. PE-constricted aorta tissues from female (A-C) and male (D-F); wild-type (wt/wt) (A, D), HSPB1-null (À/À) (B, E) and HSPB1-overexpressing (o/e) mice (C, F) were treated with increasing concentrations of 2-fLI either in the absence or presence of 0.1 mM L-NAME or 1 μM ODQ acting either alone or in combination (L-NAME plus ODQ), and the relaxant responses were measured as outlined in the Methods. Lines represent four parameter logistic curves, which calculate the variables available on GraphPad PRISM. Variables were compared by one-way ANOVA followed by post hoc tests. *P < 0.05 PE alone versus + L-NAME alone; #P < 0.05, + L-NAME alone versus ODQ and L-NAME and ODQ in combination.
was in play (Supporting Information Figures S3 and S4) . Further, we reasoned that this hyperpolarizing effect of residual NO could be due to the activation of endothelial calciumactivated K Ca channels. In this regard, we found that in combination, Apamin, TRAM-34 and Iberiotoxin could abolish the L-NAME-resistant vasorelaxant effect of 2-fLI in the wild-type female-derived tissues, but not entirely in tissues from the HSPB1-null females (Supporting Information Figures S5A-D) . The addition of the EET antagonist, EEZE, was able to eliminate the residual relaxant response of the HSPB1-null female tissues (Supporting Information Figure  S5D ). In contrast, as mentioned above, the addition of the cyclooxygenase inhibitor, indomethacin (up to 10 μM), had no effect on the vasorelaxant responses in any of the tissues (not shown). In summary, our data showed as follows: (i) that the vasodilator/relaxant responses to PAR2 stimulation were greater than those due to muscarinic receptor activation in the female-derived tissues, compared with the males; (ii) that L-NAME-resistant PAR2-stimulated relaxation was greater for female-derived tissues from wild-type and HSPB1-null mice versus the tissues from the other animals; and (iii) That overexpression of HSPB1 in the female mice attenuated the L-NAME-resistant component of relaxation for both muscarinic and PAR2 activation (compare Figure 2C vs. 3C) . Further, the data indicated that the residual relaxant actions of 2-fLI and ACh in the presence of L-NAME were abolished in the combined presence of L-NAME and ODQ and involved calcium-activated K Ca channels along with a hyperpolarizing effect that was diminished in the presence of elevated extracellular K + .
Increased mRNA for eNOS and soluble guanylyl cyclase α subunit isoforms, Gucy1a1 and Gucy1a2, in female versus male mice
Given the greater resistance to L-NAME of the agonistmediated vasorelaxant response in the tissues from the female mice, as compared with the males, particularly in comparing the female and male HSPB1-null mice (compare panels B and E of Figures 2 and 3) , we wondered if the abundance of eNOS mRNA might differ between males and females. Further, since the residual L-NAME-resistant relaxation in the female mice was blocked by the guanylyl cyclase inhibitor, ODQ, we wondered if the abundance of mRNAs for the soluble guanylyl cyclase α-subunits necessary for NO-stimulated cyclic GMP production, Gucy1a1 and Gucy1a2, might differ between males and females. Real-time PCR analysis showed that there was a 10-to 15-fold increased abundance of mRNA for eNOS in either the wildtype or HSPB1-null female mice, compared with the males (Figure 5A, D) . This increased abundance of eNOS mRNA relative to the males was substantially reduced in the HSPB1-overexpressing female mice ( Figure 5A , right-hand histograms). Further, the abundances of mRNAs for Gucy1a1 and Gucy1a2 were greater (about 2.5-to 4-fold) in the female versus male murine aorta tissue ( Figure 5B , C).
Treatment of aorta tissue from HSPB1-null female mice with recombinant HSP27 restores sensitivity of the vasodilator response to L-NAME
As shown in Figures 2 and 3 , there is a significant proportion of the vasodilator/relaxant response to ACh (Figure 2A , B) and 2-fLI ( Figure 3A , B) in the tissues from the female wild-type and HSPB1-null mice that is L-NAME resistant. In contrast, the aorta rings from the HSPB1 overexpressing female mice exhibited a much reduced proportion of L-NAME-resistant relaxation stimulated by either ACh or 2-fLI ( Figures 2C and 3C) . In previous work, it was found that exogenously added recombinant HSP27 can activate cultured macrophage-like THP-1 cells . We therefore hypothesized that treatment of the intact aorta tissue obtained from the HSPB1-null female mice with the recombinant protein, rHSP27, would reverse the L-NAME-resistant
Figure 4
Concentration-response curves for relaxation induced by ACh, 2-fLI/PAR2 and SNP in aorta tissue obtained from ovariectomized mice. PE-constricted aorta tissues from ovariectomized females: wild-type (wt/wt), HSPB1-null (À/À) and HSPB1-overexpressing (o/e) mice were treated with increasing concentrations of ACh (A), 2-fLI (B) and SNP (C) either in the absence or presence of 0.1 mM L-NAME, and the relaxant responses were measured as outlined in the Methods. Lines represent four parameter logistic curves which calculate the variables available on GraphPad PRISM.
Variables were compared by one-way ANOVA followed by post hoc tests. *P < 0.05, untreated tissues versus tissues + L-NAME.
relaxant effect and restore the ability of L-NAME to block the relaxant response. This hypothesis was thus tested in the HSPB1-null female mice which showed the maximum vasodilator response in the presence of L-NAME, compared with tissues from the other animals. As shown in Figure 6 and Supporting Information Figure S6 , treatment of the female HSPB1-null aorta tissue with rHSP27 for either a short time period (3 h; Figure 6 ) or for 24 h (Supporting Information Figure S6 ) was sufficient to eliminate the L-NAME-resistant vasodilatation stimulated by either 2-fLI ( Figure 6B and Supporting Information Figure S6B ) or ACh ( Figure 6A and Supporting Information Figure S6A ) (compare orange squares vs. solid circles). The inactive HSP27 N-terminaltruncated mutant of HSP27 (rC1), prepared as for rHSP27, used as a control was inactive in this regard (not shown).
This lack of vasodilator response in the presence of L-NAME in the rHSP27-treated tissues mimicked the results seen with tissues from the HSPB1-overexpressing female mice (Figure 3 C). We found that the effect of added rHSP27 to restore the tissue sensitivity to L-NAME observed at 3 h was not observed at shorter time points (30 min up to 1 h; not shown).
Enhanced L-NAME sensitivity in tissues from HSPB1-overexpressing female mice was not due to the influence of oestrogen
As the work mainly focused on sex-selective differences and since the abundance of HSPB1 is oestrogen dependent, we next sought to know whether the effect of increased levels of HSPB1 to increase the effect of L-NAME in the
Figure 5
Aorta tissues from female mice have increased eNOS and guanylyl cyclase alpha-subunit mRNAs relative to male-derived tissues. (A-C) The histograms show the qPCR analyses of mRNA isolated from male and female aorta tissue to quantify the eNOS, Gucy1a2 and Gucy1a1 mRNA levels.
Increased mRNA levels for all of the mRNAs were observed in female compared with male derived tissues. The qPCR measurements were normalized to signals for the TATA-box binding protein (TBP) levels. Data were then normalized to males and expressed as a relative abundance (fold change, compared to males) (mean ± SD: *P < 0.05 male vs. female mRNA levels).
Figure 6
HSPB1/HSP27 treatment augments L-NAME sensitivity for blocking vasodilatation mediated by muscarinic receptors and PAR2 in female HSPB1-null aorta tissue. Female HSPB1-null aortic ring tissues cultured in euglycaemic serum-free medium (DMEM: 10 mM glucose) for 3 h at 37°C were untreated or were treated with 50 μg·mL À1 (2.2 μM) recombinant HSP27 and were then evaluated for ACh (A) or 2-fLI (B)-mediated vasodilatation in the absence or presence of 0.1 mM L-NAME as outlined in the Methods. L-NAME was able to eliminate vasodilatation completely in the HSPB1-treated tissues . Concentration-response data represent four parameter logistic curves calculated using GraphPad PRISM. Variables were compared by one-way ANOVA followed by post hoc tests. *P < 0.05, for HSP27-treated tissues or untreated tissues versus L-NAME alone or HSP27 along with L-NAME. #P < 0.05, for untreated tissues plus L-NAME versus HSP-27-treated tissues plus L-NAME. ) and HSPB-null (HSPB1 À/À ) mice all showed a 60 to 80% relaxation response caused by either ACh or 2-fLI (Figure 4) . The relaxant responses to ACh and 2-fLI were equivalent in all animals. Upon L-NAME addition to tissues from the ovariectomized HSPB1-overexpressing HSPB1 o/e mice, there was no difference in relaxation compared with the intact mice (compare Figures 2C and 3C with 4A, B) . Thus, the effect of increased levels of HSPB1 in the overexpressing mice could not be attributed to oestrogen action. That said, in tissues from the ovariectomized HSPB1-null mice, L-NAME had a more pronounced inhibitory action for ACh and 2-fLImediated relaxation than in tissues from the intact animals (compare Figures 2B and 3B with 4A, B) . Thus, the absence of HSPB1 may have unmasked an oestrogen-dependent impact on the vascular action of L-NAME that was not observed in the wild-type or HSPB1-overexpressing mice.
Lack of effect of HSPB1 expression on blood pressure regulation
Given that the absence of HSPB1 affected endothelial function, we evaluated the potential effects of HSPB1 absence or overexpression on blood pressure. As shown in the Supporting Information figures, for either female (Supporting Information Figure S7 , histograms A to I; and representative tracings in Supporting Information Figure S7J ) or male mice (Supporting Information Figure S8 , histograms A to I; and representative tracings in Supporting Information Figure S8J ), there were no differences in the ambient systolic/diastolic blood pressures, the hypertensive effect of PE or the blood pressure lowering effect of ACh between the different mouse strains, including the HSPB1-nulls, the wild-type and HSPB1-overexpressing mice.
Discussion
Since their discovery as cell stress-responsive genes, HSPs, including HSP27, have been found to play many roles in addition to their 'chaperoning' function that enables protein folding and intracellular transit (Lianos et al., 2015; Batulan et al., 2016; Arrigo, 2017) . The work we describe here amplifies data obtained by us and others demonstrating that apart from its intracellular actions, HSP27 can act as an extracellular regulator of cell signalling, possibly via a receptor-mediated mechanism (Calderwood et al., 2007; Salari et al., 2013) . This signalling action of HSP27 bears on diverse pathologies related to cardiovascular disease (Rayner et al., 2010; Cuerrier et al., 2013; Raizman et al., 2013; Seibert et al., 2013; Batulan et al., 2016; Pulakazhi Venu et al., 2017) . Given the impact of rHSP27 in vitro on cultured THP-1 macrophages and endothelial progenitor cells, our aim was to determine if the protein acting in vivo could affect the function of the endothelium in intact aorta tissue Ma et al., 2014) . Our main finding was that relative to the males, the female-derived tissues were much less sensitive to the blockade of the vasodilator response by L-NAME acting on its own; and the female tissues devoid of HSP27 were even more resistant to L-NAME blockade than any of the other tissues (Figures 2 and 3 ). These differences can be correlated with the increased expression of mRNA for eNOS and two guanylyl cyclase isoforms (Gucy1a1 and Gucy1a2) in the female tissues. Thus, in the HSPB1-null female-derived tissues, there was a vasodilator response that was still observed in the presence of either L-NAME or ODQ acting alone at concentrations that efficiently blocked the vasodilator responses in tissues from the other male and female animals. However, in the male mice, neither the overexpression nor elimination of HSPB1 affected the ability of L-NAME to block the vasodilator actions of either ACh or 2-fLI; and the tissues from the HSP27-overexpressing females were as sensitive to L-NAME blockade as were the male-derived tissues. Notwithstanding, the combined actions of L-NAME and ODQ were able to eliminate the vasodilator responses in all the female-derived tissues. Comparing the actions of these inhibitors alone or in combination, we were able to unmask the differences between the tissues from the wild-type and HSPB1-null female mice, compared with the male-derived vessels.
Our data showing that the combined actions of L-NAME and ODQ acting together were able to block the relaxant response in tissues and that the relaxant response in the presence of L-NAME alone was attenuated in the presence of elevated extracellular potassium indicating a hyperpolarization mechanism are entirely in accord with the observations of Cohen et al. (1997) , who observed a non-Endothelium derived hyperpolarizing factor (EDHF), NO-dependent hyperpolarization-mediated vasodilatation of rabbit carotid artery tissue even in the presence of relatively high concentrations of L-NAME (up to 0.3 mM). Further, the L-NAME-resistant relaxation caused by PAR2 activation was attenuated by the combined action of inhibitors of small, medium and large calcium-activated K Ca conductance channels in tissues from all mouse strains. Of note, in tissues from the HSPB1-null female mice, the addition of the EET inhibitor, EEZE was required to eliminate a small residual L-NAME-resistant relaxation observed in the combined presence of all three K Ca channel blockers. This result affirmed the difference between the female HSPB1-null tissues compared with the other female and male-derived tissues.
In contrast with our data obtained for male-derived tissues, the overexpression of HSPB1 in females resulted in an enhancement of the impact of L-NAME acting alone to block a vasorelaxant effect (compare Figures 2C and 3C with Figures 2A, B and 3A, B) . The impact of overexpressing HSPB1 on the sensitivities of female tissues to L-NAME did not depend on ovarian hormones (e.g. oestrogen), since ovariectomy did not change the effect of L-NAME ( Figure 4A, B) . That said, the data obtained from the ovariectomized HSPB1-null mice revealed an increased sensitivity of the tissues towards the inhibitory action of L-NAME (compare Figure 4A , B with Figures 2A, B  and 3A, B) . Thus, the absence of HSPB1 appeared to unmask an unexpected impact of ovarian hormones (e.g. oestrogen) on endothelial function in terms of L-NAME sensitivity.
The mechanisms for vasodilatation of the female-derived tissues that persists in the presence of either L-NAME or ODQ acting alone, but is blocked in the combined presence of L-NAME and ODQ, remain to be determined. The resistance to L-NAME for PAR2-induced relaxation in the female tissues may relate to differences between the PAR2 responsiveness of male and female-derived murine vascular tissue reported previously (Hennessey and McGuire, 2013) . It is also possible that the effects may relate in some way to a constitutive activation of protein kinase G triggered either by residual NO or, as suggested by Greenstein, Nelson and colleagues (Khavandi et al., 2016) , by oxidative stress. In keeping with this possibility, we found an increase in mRNA for both eNOS and the α-subunit isoforms of the soluble NO-sensitive guanylyl cyclase isoforms, Gucy1a1 and Gucy1a2, in the female tissues compared with those from the males (Figure 5 A-C). Although the increased mRNAs might not correlate directly with protein content, the data suggest that even at relatively high inhibitory concentrations of L-NAME, the increased eNOS could generate minimal but sufficient NO to drive guanylyl cyclase activity, so as to result in a vasodilator response. This abundance of eNOS and soluble guanylyl cyclase mRNAs might possibly explain the L-NAME-resistant relaxation observed in rabbit carotid artery tissue (Cohen et al., 1997) .
Our findings are the first to indicate that HSPB1 can in principle have a 'hormone-like' effect on vascular tissues in vivo and in vitro, acting on a presumed extracellular receptor to affect intact vascular endothelial function, particularly in females. The impact of treating aorta tissues in vitro with recombinant HSP27 to enhance the tissue sensitivity to L-NAME that required more than 1 h exposure to the protein very likely involves a complex process involving both transcriptional regulation and rHSP27 internalization. Although the effect of rHSP27 was monitored by observing changes in the L-NAME blockade of eNOS-mediated relaxation, an effect on tissue elements other than the endothelium cannot be ruled out because the entire tissue was present in the organ culture. Further work is thus merited to determine the precise mechanism whereby exogenous HSPB1 affects vascular function; and it remains to be seen if endothelial functions such as barrier permeability and leukocyte-endothelial transcytosis, apart from the release of vasorelaxants (NO, EET), may also be regulated by HSPB1. Further, the effect of HSPB1 on small calibre resistance vessels like mesenteric arteries (McGuire et al., 2002) , as opposed to capacitance vessels like the aorta that we describe here, would be expected to differ. That issue thus merits evaluation in the future.
Although HSPB1 altered endothelial function in terms of its sensitivity to L-NAME and ODQ acting on their own, its absence did not appear to have an impact on vascular contractility per se in the HSPB1-null female tissues. Thus, the concentration-effect curves for PE-induced contraction ( Figure 1) ; and the sensitivity of the vasculature to NO-donor-mediated relaxation (Supporting Information Figure S2 ) did not differ in the female mice that either overexpressed or did not express HSPB1. Further, even though the magnitude of L-NAME-resistant relaxation was greater in the female HSPB1-null vessels compared with the other female and male mouse strains (e.g. Figures 2B and 3B) , the overall maximal relaxant response of the vessels to either ACh or 2-fLI did not differ between the wild-type and HSPB1-null tissues; and we found no difference between the several mouse strains in terms of blood pressure parameters measured in vivo. The consequence of this change in endothelial function may thus bear on other aspects of endothelial mechanisms apart from regulating blood pressure. This issue fully merits further study. The main implication of our findings is that the potential role of HSPB1 itself in regulating vascular function may be different between males and females and from one pathology to another, for example, tissue inflammation versus atherosclerosis.
In summary, our data indicate that HSPB1, either as an endogenously produced or as an exogenously added agonist, can have an effect on endothelial function in intact vascular tissue, particularly in females, affecting the levels of mRNA for eNOS and soluble guanylyl cyclase and the proportion of vasorelaxation that is sensitive to the action of L-NAME. This greater impact of HSPB1 in female versus male vascular tissue may relate to the increased abundance in female tissues of mRNAs for eNOS and the NO-targeted α subunits of soluble guanylyl cyclase. These findings substantiate the multiple roles that HSPB1 can have in regulating endothelial function in many pathological settings, particularly in females.
calculate the variables available on graph pad PRISM. Variables were compared by one -way ANOVA followed by posthoc tests. * P < 0.05 for male HSPB1À/À vs HSPB1wt/wt and HSPB1o/e. Figure S3 Impact of elevated extracellular potassium on L-NAME resistant relaxation for ACh-mediated vasodilator/relaxant responses in wild-type, HSPB1-null and HSPB1-overexpressing mice. Tissues from female (A-C) and male (D-F) wild-type (wt/wt) (A, D), HSPB1-null (À/À) (B, E) and HSPB1-overexpressing (o/e) (C, F) mice were constricted with 2.5 μM PE and the relaxant response to 3 μM ACh was measured in the presence of 0.1 mM L-NAME alone (solid histograms) or in combination with 15 mM KCl (open histograms). *P < 0.05, +L-NAME vs + L-NAME+KCl; **P < 0.01 + L-NAME vs + L-NAME+ KCl. Figure S4 Effect of elevated extracellular potassium on L-NAME resistant relaxation for PAR2-mediated relaxant responses in wild-type, HSPB1-null and HSPB1-overexpressing mice. Tissues from female (A-C) and male (D-F) wild-type (wt/wt) (A, D), HSPB1-null (À/À) (B, E) and HSPB1-overexpressing (o/e) (C, F) mice were constricted with 2.5 μM PE and the relaxant response to 1 μM 2-fLI was measured in the presence of 0.1 mM L-NAME alone (solid histograms) or in combination with 15 mM KCl (open histograms). *P < 0.05, +L-NAME vs + L-NAME+KCl. Figure S5 2-fLI mediated relaxation reduced in presence of L-NAME is attenuated further in the presence of BK Ca , IK Ca , SK Ca and EET inhibitors. Rings from female (A-B) and male (C-D) wild-type (wt/wt) (A-C) and HSPB1-null (À/À) (B-D) mice were constricted with 2.5 μM PE and the relaxation-response curves for increasing concentrations of 2-fLI (panels A-D) were measured in the absence (magenta circles) or presence of 0.1 mM L-NAME either alone (orange squares) or in combination with various channel inhibitors [apamin (Apa), TRAM-34 and Iberiotoxin (IBTX)] or with the EET inhibitor, EEZE, as indicated. *P < 0.05, 2-fLI alone versus 2-fLI plus inhibitor combinations; # P < 0.05, L-NAME alone vs LNAME+Apa + IBTX+TRAM-34 and L-NAME+Apa + TRAM-34 for Panel A; # P < 0.05, +L-NAME alone vs L-NAME+Apa Figure S6 HSPB1/HSP27 treatment over 24 hours augments L-NAME-sensitive relaxation for Muscarinic and PAR2 activation in female HSPB1-null aorta tissue. Female HSPB1-null aorta tissue cultured at 37°C in euglycaemic DMEM (10 mM glucose) for 24 hours (A, B) were either untreated or were treated with 50 μg·mL À1 (2 μM) recombinant HSP27
for 24 hours and were studied for the relaxant activity stimulated by either acetylcholine (A) or 2-fLI (B) as outlined in Methods. Relaxation-response curves were obtained for increasing concentrations of either acetylcholine (A) or 2-fLI (B) in either the absence or presence of 0.1 mM L-NAME. L-NAME was able to reverse completely, the relaxation of tissues incubated with HSP27 but not for the tissues cultured in the absence of HSP27 * P < 0.05 untreated or HSP27 treated vs + L-NAME and HSP-27 + L-NAME. # P < 0.05, for untreated tissues plus L-NAME (orange squares) versus HSP27-treated tissues plus L-NAME (black circles). V K Pulakazhi Venu et al.
